This section is intended for subscribers of AHFS Drug Information 2017 Edition and includes electronic only monographs. To access, you will be required to login with a username and password, which can be found in the preface of each annual edition of AHFS DI.
ASHP Drug Shortages Center
Drug Class Assignments and Reassignments
Investigational Drug Services Resource Center
Medications and Suicidality Resource Center
REMS Resource Center
Sterile Compounding Resource Center
Off-label Uses in AHFS
National Alert Network
ASHP Best Practices
AHFS Drug Information/Essentials Update – April 20174 April, 2017
Ocrevus (ocrelizumab) Approved29 March, 2017
Dupixent (dupilumab) Approved29 March, 2017
ASHP represents pharmacists who serve as patient care providers in acute and ambulatory settings. The organization’s more than 43,000 members include pharmacists, student pharmacists, and pharmacy technicians. For over 70 years, ASHP has been at the forefront of efforts to improve medication use and enhance patient safety. For more information about the wide array of ASHP activities and the many ways in which pharmacists advance healthcare, visit ASHP’s website, www.ashp.org, or its consumer website, www.safemedication.com.